"Glycolipids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage)
| Descriptor ID |
D006017
|
| MeSH Number(s) |
D09.400.410 D10.390
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glycolipids".
Below are MeSH descriptors whose meaning is more specific than "Glycolipids".
This graph shows the total number of publications written about "Glycolipids" by people in this website by year, and whether "Glycolipids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glycolipids" by people in Profiles.
-
Lawson PA, Patel NB, Mohammed A, Moore ERB, Lo AS, Sardi A, Davis JM, Doyle DA, Hui Y, Testerman T. Parapseudoflavitalea muciniphila gen. nov., sp. nov., a member of the family Chitinophagaceae isolated from a human peritoneal tumour and reclassification of Pseudobacter ginsenosidimutans as Pseudoflavitalea ginsenosidimutans comb. nov. Int J Syst Evol Microbiol. 2020 Jun; 70(6):3639-3646.
-
Zhang X, Tu B, Dai LR, Lawson PA, Zheng ZZ, Liu LY, Deng Y, Zhang H, Cheng L. Petroclostridium xylanilyticum gen. nov., sp. nov., a xylan-degrading bacterium isolated from an oilfield, and reclassification of clostridial cluster III members into four novel genera in a new Hungateiclostridiaceae fam. nov. Int J Syst Evol Microbiol. 2018 Oct; 68(10):3197-3211.
-
Olino K, Edil BH, Meckel KF, Pan X, Thuluvath A, Pardoll DM, Schulick RD, Yoshimura K, Weber WP. Glycolipid antigens for treating hepatic colorectal cancer metastases and their effect on the therapeutic efficacy of live attenuated Listeria monocytogenes. Arch Surg. 2012 May; 147(5):480-2.
-
Devera TS, Joshi SK, Aye LM, Lang GA, Ballard JD, Lang ML. Regulation of anthrax toxin-specific antibody titers by natural killer T cell-derived IL-4 and IFN?. PLoS One. 2011; 6(8):e23817.
-
Devera TS, Shah HB, Lang GA, Lang ML. Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers. Eur J Immunol. 2008 Apr; 38(4):1001-11.
-
Lang GA, Maltsev SD, Besra GS, Lang ML. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts. Immunology. 2004 Jul; 112(3):386-96.
-
Lang ML, Chen YW, Shen L, Gao H, Lang GA, Wade TK, Wade WF. IgA Fc receptor (FcalphaR) cross-linking recruits tyrosine kinases, phosphoinositide kinases and serine/threonine kinases to glycolipid rafts. Biochem J. 2002 Jun 01; 364(Pt 2):517-25.
-
Li F, Chen H, Anderson RE. Biosynthesis of docosahexaenoate-containing glycerolipid molecular species in the retina. J Mol Neurosci. 2001 Apr-Jun; 16(2-3):205-14; discussion 215-21.
-
Clark MR, Sorette MP. Characterization of antibody that binds in vivo to normal human red blood cells. Adv Exp Med Biol. 1991; 307:357-65.